EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-1.53%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.26B
AUM Growth
-$105M
(-7.7%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34
Top Buys
| 1 |
Pinduoduo
PDD
|
$52.2M |
| 2 |
KE Holdings
BEKE
|
$28.2M |
| 3 |
TSMC
TSM
|
$11.8M |
| 4 |
Kanzhun
BZ
|
$5.71M |
| 5 |
iQIYI
IQ
|
$4.15M |
Top Sells
| 1 |
Tencent Music
TME
|
$38.3M |
| 2 |
Trip.com Group
TCOM
|
$19.3M |
| 3 |
Marvell Technology
MRVL
|
$14.8M |
| 4 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$7.98M |
| 5 |
Microsoft
MSFT
|
$6.65M |
Sector Composition
| 1 | Consumer Discretionary | 37.28% |
| 2 | Technology | 32.43% |
| 3 | Communication Services | 9.6% |
| 4 | Healthcare | 8.37% |
| 5 | Real Estate | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Union Pacific
UNP
$131B
| $209K | 0.02% |
1,019
-121
| -11% | -$24.8K |
|
277
Allogene Therapeutics
ALLO
$255M
| $204K | 0.02% |
41,061
+2,624
| +7% | +$13K |
|
278
Edwards Lifesciences
EW
$47.5B
| $201K | 0.02% |
2,126
-323
| -13% | -$30.5K |
|
279
Boeing
BA
$174B
| $200K | 0.02% |
945
-103
| -10% | -$21.8K |
|
280
GE Aerospace
GE
$296B
| $200K | 0.02% |
+2,279
| New | +$200K |
|
281
VeriSign
VRSN
$26.2B
| $200K | 0.02% |
886
-103
| -10% | -$23.3K |
|
282
Seres Therapeutics
MCRB
$169M
| $199K | 0.02% |
2,079
+1,400
| +206% | +$134K |
|
283
AT&T
T
$212B
| $190K | 0.02% |
11,939
-1,338
| -10% | -$21.3K |
|
284
Day One Biopharmaceuticals
DAWN
$773M
| $187K | 0.01% |
15,641
+4,774
| +44% | +$57.1K |
|
285
Scilex Holding
SCLX
$159M
| $175K | 0.01% |
898
| – | – |
|
|
DCPH
286
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $175K | 0.01% |
12,429
-859
| -6% | -$12.1K |
|
287
CareDx
CDNA
$736M
| $157K | 0.01% |
18,437
-4,685
| -20% | -$39.9K |
|
|
CDMO
288
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $154K | 0.01% |
10,990
+953
| +9% | +$13.4K |
|
289
Anavex Life Sciences
AVXL
$807M
| $153K | 0.01% |
18,853
-7,561
| -29% | -$61.4K |
|
290
ADMA Biologics
ADMA
$4.03B
| $142K | 0.01% |
38,613
-17,090
| -31% | -$62.8K |
|
291
SiriusXM
SIRI
$8.1B
| $135K | 0.01% |
2,973
-492
| -14% | -$22.3K |
|
292
Cogent Biosciences
COGT
$1.82B
| $131K | 0.01% |
11,088
-2,661
| -19% | -$31.4K |
|
293
Recursion Pharmaceuticals
RXRX
$2.01B
| $129K | 0.01% |
17,229
-4,188
| -20% | -$31.4K |
|
|
TSVT
294
DELISTED
2seventy bio
TSVT
| $126K | 0.01% |
12,420
-181
| -1% | -$1.84K |
|
|
AGEN
295
Agenus
AGEN
$138M
| $124K | 0.01% |
3,866
-2,444
| -39% | -$78.4K |
|
296
uniQure
QURE
$985M
| $122K | 0.01% |
10,653
-1,593
| -13% | -$18.2K |
|
297
Viatris
VTRS
$12.2B
| $120K | 0.01% |
12,016
+130
| +1% | +$1.3K |
|
298
Aldeyra Therapeutics
ALDX
$334M
| $114K | 0.01% |
+13,612
| New | +$114K |
|
299
Kura Oncology
KURA
$713M
| $112K | 0.01% |
10,628
-4,960
| -32% | -$52.3K |
|
300
Sana Biotechnology
SANA
$752M
| $108K | 0.01% |
18,054
-5,126
| -22% | -$30.7K |
|